YABAO PHARMACEUTICAL GROUP CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.56 CNY | -0.30% |
|
-2.96% | -4.93% |
Business Summary
Number of employees: 4,367
Sales per Business
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceutical Production - Pediatrics
31.0
%
| 610 | 22.4 % | 901 | 31.0 % | +47.83% |
Pharmaceutical Production - Cardiovascular System
26.6
%
| 798 | 29.4 % | 775 | 26.6 % | -2.91% |
Pharmaceutical Wholesale
14.9
%
| 427 | 15.7 % | 433 | 14.9 % | +1.45% |
Pharmaceutical Production - Other
5.7
%
| 156 | 5.7 % | 165 | 5.7 % | +5.81% |
Pharmaceutical Production - Raw Materials
4.9
%
| 114 | 4.2 % | 143 | 4.9 % | +25.28% |
Pharmaceutical Production - Psychiatry and Neurology
3.9
%
| 150 | 5.5 % | 113 | 3.9 % | -25.15% |
Pharmaceutical Production - Endocrine System
3.4
%
| - | - | 99 | 3.4 % | - |
Pharmaceutical Production - Pain Relief
2.7
%
| 197 | 7.3 % | 79 | 2.7 % | -60.06% |
Pharmaceutical Production - Digestive System
2.7
%
| 79 | 2.9 % | 79 | 2.7 % | -0.91% |
Pharmaceutical Production - Anti-infection
1.6
%
| 35 | 1.3 % | 46 | 1.6 % | +33.64% |
Other Trade
1.1
%
| 34 | 1.3 % | 33 | 1.1 % | -3.19% |
Other Business
1.0
%
| 37 | 1.4 % | 29 | 1.0 % | -21.34% |
Pharmaceutical Production - Gynecology
0.5
%
| 11 | 0.4 % | 15 | 0.5 % | +44.22% |
Sales per region
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
China
100.0
%
| 2,718 | 100.0 % | 2,910 | 100.0 % | +7.05% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Ren
CEO | Chief Executive Officer | 40 | 23/19/23 |
Zhe Feng Zuo
DFI | Director of Finance/CFO | 52 | - |
Wu Xian Ren
CHM | Chairman | 64 | - |
Peng Bo Ren
BRD | Director/Board Member | 51 | 11/07/11 |
Ying Kang Yang
IRC | Investor Relations Contact | - | - |
Yu Hong Yu
PRN | Corporate Officer/Principal | 52 | 23/11/23 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wu Xian Ren
CHM | Chairman | 64 | - |
Zhen Jiang Xu
CHM | Chairman | 51 | 15/14/15 |
Peng Bo Ren
BRD | Director/Board Member | 51 | 11/07/11 |
Wei Ren
CEO | Chief Executive Officer | 40 | 23/19/23 |
Bin Wu
BRD | Director/Board Member | 64 | 18/23/18 |
Hui Qiang Ning
BRD | Director/Board Member | 54 | 16/20/16 |
Gang Wang
BRD | Director/Board Member | 50 | 16/20/16 |
Junyan Liu
BRD | Director/Board Member | 58 | 16/20/16 |
Chun jiang Yu
BRD | Director/Board Member | 54 | 16/20/16 |
Yong Tan
BRD | Director/Board Member | 46 | 16/20/16 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 770,000,023 | 602,443,717 ( 78.24 %) | 49,999,929 ( 6.493 %) | 78.24 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
| 10,000,000 | 1.30% | 9,058,900 $ |
Company contact information
Yabao Pharmaceutical Group Co., Ltd.
11/F, Building 2, Yard 11 Tianhua North Street
100176, Beijing
+86 35 9338 8114
http://www.yabao.com.cn
Sector
Sales per Business
| 1st Jan change | Capi. | |
|---|---|---|
| -4.93% | 66Cr | |
| +21.59% | 4.42TCr | |
| +23.03% | 2.3TCr | |
| +18.22% | 1.53TCr | |
| +12.26% | 1.37TCr | |
| +52.55% | 1.22TCr | |
| -10.02% | 683.92Cr | |
| -0.05% | 678.76Cr | |
| -8.87% | 572.55Cr | |
| +13.88% | 565.87Cr |
- Stock Market
- Equities
- 600351 Stock
- Company Yabao Pharmaceutical Group Co., Ltd
